Physician profile
Maureen Cernadas
NPI 1427137066
$3,503.36
in general payments reported to CMS, 2019-2025
13 companies · $199 in 2025
The $199 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,634 · 2020: $11.94 · 2021: $231 · 2022: $1,056 · 2023: $220 · 2024: $152 · 2025: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $570.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $570.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,702.00 | 2019-2023 | |
| Davol INC. | $309.23 | 2021-2023 | Arista Ah Flexitip |
| Abbvie INC. | $118.07 | 2022-2023 | Lo Loestrin Fe |
| Baxter Healthcare | $113.01 | 2025 | Tisseel |
| Astellas Pharma US INC | $83.79 | 2024 | Veozah |
| Organon LLC | $50.74 | 2024 | |
| Sumitomo Pharma America, INC. | $33.43 | 2025 | Myfembree |
| Sanofi Pasteur INC. | $17.60 | 2025 | |
| Sage Therapeutics, LLC | $17.28 | 2025 | Zurzuvae |
| Supernus Pharmaceuticals, INC. | $17.28 | 2025 | Qelbree |
| Evofem Biosciences, INC. | $17.00 | 2024 | |
| Agile Therapeutics, INC. | $11.99 | 2021 | |
| Avion Pharmaceuticals | $11.94 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maureen Cernadas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.